---
title: "Majestic Ideal Holdings Ltd Approves Name Change to Ping An Biomedical Co., Ltd."
description: "Majestic Ideal Holdings Ltd has received shareholder approval to change its name to Ping An Biomedical Co., Ltd. during an Extraordinary General Meeting on September 12, 2025. This name change, pendin"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/257371338.md"
published_at: "2025-09-15T12:24:22.000Z"
---

# Majestic Ideal Holdings Ltd Approves Name Change to Ping An Biomedical Co., Ltd.

> Majestic Ideal Holdings Ltd has received shareholder approval to change its name to Ping An Biomedical Co., Ltd. during an Extraordinary General Meeting on September 12, 2025. This name change, pending approval from the Cayman Islands Registrar of Companies, reflects the company's strategic focus on biomedical and healthcare technologies, aiming to enhance its corporate image and support its mission of innovation in the industry.

An update from Majestic Ideal Holdings Ltd ( (MJID) ) is now available.

On September 12, 2025, Majestic Ideal Holdings Ltd held an Extraordinary General Meeting where shareholders approved a special resolution to change the company’s name to ‘Ping An Biomedical Co., Ltd.’, subject to the approval of the Registrar of Companies in the Cayman Islands. The name change aligns with the company’s strategic focus on biomedical and healthcare technologies and aims to enhance its corporate image. The Board of Directors believes this change will support the company’s mission to drive innovation and strengthen its positioning in the industry.

**More about Majestic Ideal Holdings Ltd**

Majestic Ideal Holdings Ltd is a one-stop supply chain management service provider in the apparel industry. The company is also focused on delivering innovative solutions in healthcare and biomedical technology, reflecting its commitment to advancing its mission and positioning itself as a leader in the industry.

**Average Trading Volume:** 1,865,302

### Related Stocks

- [MJID.US - Majestic Ideal](https://longbridge.com/en/quote/MJID.US.md)
- [PASW.US - Ping An Biomedical](https://longbridge.com/en/quote/PASW.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Allscripts 医疗｜8-K：2025 财年营收 5.87 亿美元 |  | [Link](https://longbridge.com/en/news/276168463.md) |
| ICU 医疗｜10-K：2025 财年营收 22.31 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276382836.md) |
| 早盘趋势｜佰泽医疗筑底盘整，低位震荡分时异动要来了？ | 2 月 3 日，佰泽医疗（2609.HK）全天维持缩量震荡，筑底盘整格局依旧。医疗服务板块本周缺乏政策利好，主流资金普遍等待更确切指引。短线关注点聚焦于底部盘整区域能否获得承接，部分资金盘中试探低吸。技术面信息同样偏弱，日线 MACD 死叉 | [Link](https://longbridge.com/en/news/274634340.md) |
| AgelessRx 在癌症预防月期间扩大了多癌症早期检测解决方案的可及性 | AgelessRx 正在扩大其多癌种早期检测解决方案的可及性，以纪念癌症预防月。该倡议旨在增强筛查工具的可用性，以便在早期阶段识别潜在的癌症信号。该公司正在优化其流程，以便更好地提供这些解决方案，这些方案分析血液样本中与多种癌症类型相关的生 | [Link](https://longbridge.com/en/news/276180967.md) |
| Inmar Intelligence 获得了与 Premier, Inc.续签的药房逆向分销协议 | Inmar Intelligence 已与 Premier, Inc. 签署了一份更新的国家级药房逆向分销服务团体采购协议，该协议将于 2026 年 2 月 1 日生效。该协议允许 Premier 的成员享受预先谈判的价格和条款。Inmar | [Link](https://longbridge.com/en/news/276352016.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
